Anco Boonstra

6.4k total citations · 1 hit paper
71 papers, 4.5k citations indexed

About

Anco Boonstra is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Anco Boonstra has authored 71 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 47 papers in Cardiology and Cardiovascular Medicine and 11 papers in Surgery. Recurrent topics in Anco Boonstra's work include Pulmonary Hypertension Research and Treatments (61 papers), Cardiovascular Function and Risk Factors (30 papers) and Vascular Anomalies and Treatments (10 papers). Anco Boonstra is often cited by papers focused on Pulmonary Hypertension Research and Treatments (61 papers), Cardiovascular Function and Risk Factors (30 papers) and Vascular Anomalies and Treatments (10 papers). Anco Boonstra collaborates with scholars based in Netherlands, United States and Switzerland. Anco Boonstra's co-authors include Anton Vonk Noordegraaf, J. Tim Marcus, Pieter E. Postmus, Nico Westerhof, Harm Jan Bogaard, C. Tji Gan, Koen Marques, Mariëlle C. van de Veerdonk, Martijn W. Heymans and Gert-Jan Mauritz and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Anco Boonstra

71 papers receiving 4.4k citations

Hit Papers

Progressive Right Ventricular Dysfunction in Patients Wit... 2011 2026 2016 2021 2011 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Progressive Right Ventricular Dysfunction in Patients With Pulmonary Arterial Hypertension Responding to Therapy
    2011 601 citations Mariëlle C. van de Veerdonk, J. Tim Marcus et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anco Boonstra Netherlands 35 3.8k 3.3k 689 535 261 71 4.5k
A. Boonstra Netherlands 20 2.3k 0.6× 1.7k 0.5× 303 0.4× 255 0.5× 314 1.2× 41 2.6k
Koen Marques Netherlands 25 2.3k 0.6× 2.6k 0.8× 508 0.7× 897 1.7× 151 0.6× 54 3.4k
Robert A. Quaife United States 23 1.1k 0.3× 2.3k 0.7× 516 0.7× 628 1.2× 69 0.3× 65 3.2k
Jörg Winkler Germany 19 1.6k 0.4× 1.2k 0.4× 158 0.2× 207 0.4× 223 0.9× 38 2.2k
Hani Shennib Canada 28 2.6k 0.7× 1.4k 0.4× 188 0.3× 1.4k 2.7× 183 0.7× 76 3.7k
Corey E. Ventetuolo United States 26 1.9k 0.5× 1.0k 0.3× 283 0.4× 405 0.8× 201 0.8× 111 2.7k
Dietmar Schranz Germany 31 1.6k 0.4× 1.3k 0.4× 2.0k 2.9× 1.2k 2.3× 150 0.6× 187 3.3k
J. Tim Marcus Netherlands 20 1.3k 0.3× 1.6k 0.5× 281 0.4× 280 0.5× 108 0.4× 30 2.1k
Daniel Staub Switzerland 29 1.4k 0.4× 1.2k 0.3× 403 0.6× 710 1.3× 72 0.3× 131 2.6k
Igor E. Konstantinov Australia 39 2.8k 0.7× 2.0k 0.6× 3.5k 5.1× 2.5k 4.6× 159 0.6× 364 6.5k

Countries citing papers authored by Anco Boonstra

Since Specialization
Citations

This map shows the geographic impact of Anco Boonstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anco Boonstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anco Boonstra more than expected).

Fields of papers citing papers by Anco Boonstra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anco Boonstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anco Boonstra. The network helps show where Anco Boonstra may publish in the future.

Co-authorship network of co-authors of Anco Boonstra

This figure shows the co-authorship network connecting the top 25 collaborators of Anco Boonstra. A scholar is included among the top collaborators of Anco Boonstra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anco Boonstra. Anco Boonstra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nossent, Esther J., Lilian J. Meijboom, Anco Boonstra, et al.. (2024). Clinical Correlates of a Nonplexiform Vasculopathy in Patients With a Diagnosis of Idiopathic Pulmonary Arterial Hypertension. CHEST Journal. 166(1). 190–200. 7 indexed citations
2.
Wezenbeek, Jessie van, Stine Andersen, Anco Boonstra, et al.. (2023). Long-Term Effects of Pulmonary Endarterectomy on Right Ventricular Stiffness and Fibrosis in Chronic Thromboembolic Pulmonary Hypertension. Circulation Heart Failure. 16(10). e010336–e010336. 9 indexed citations
3.
Meijboom, Lilian J., Onno A. Spruijt, Anton Vonk Noordegraaf, et al.. (2023). Right Ventricular Function During Exercise After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension. Journal of the American Heart Association. 12(4). e027638–e027638. 3 indexed citations
4.
Handoko, M. Louis, Lilian J. Meijboom, Esther J. Nossent, et al.. (2022). Noninvasive follow-up strategy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. ERJ Open Research. 8(2). 564–2021. 3 indexed citations
5.
Boon, Gudula J.A.M., Frances S. de Man, Josien van Es, et al.. (2021). Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension. European Respiratory Journal. 58(6). 2100699–2100699. 19 indexed citations
6.
Jacobs, Wouter, Thelma C. Konings, Martijn W. Heymans, et al.. (2015). Noninvasive identification of left-sided heart failure in a population suspected of pulmonary arterial hypertension. European Respiratory Journal. 46(2). 422–430. 32 indexed citations
7.
Delcroix, Marion, Gérald Simonneau, Emmanuel Bergot, et al.. (2013). Long-term safety of a new formulation of epoprostenol in pulmonary arterial hypertension. European Respiratory Journal. 42(Suppl 57). P4080–P4080. 1 indexed citations
8.
Henkens, Ivo R., et al.. (2012). Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension. European Respiratory Journal. 41(4). 872–878. 48 indexed citations
9.
Man, Frances S. de, Ly Tu, M. Louis Handoko, et al.. (2012). Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 186(8). 780–789. 252 indexed citations
10.
Westerhof, Nico, Gerrina Ruiter, Mark Lubberink, et al.. (2011). Systolic Pulmonary Artery Pressure and Heart Rate are Main Determinants of Oxygen Consumption in the Right Ventricular Myocardium of Patients with Idiopathic Pulmonary Arterial Hypertension. European Journal of Heart Failure. 13(12). 1290–1295. 30 indexed citations
11.
Groepenhoff, Herman, Nico Westerhof, Wouter Jacobs, et al.. (2010). Exercise Stroke Volume and Heart Rate Response Differ in Right and Left Heart Failure. European Journal of Heart Failure. 12(7). 716–720. 33 indexed citations
12.
Jacobs, Wouter, Anco Boonstra, Monika Brand, et al.. (2010). Long-term outcomes in pulmonary arterial hypertension in the first-line epoprostenol or first-line bosentan era. The Journal of Heart and Lung Transplantation. 29(10). 1150–1158. 7 indexed citations
13.
Saouti, Nabil, Nico Westerhof, Frank Helderman, et al.. (2010). Right Ventricular Oscillatory Power Is a Constant Fraction of Total Power Irrespective of Pulmonary Artery Pressure. American Journal of Respiratory and Critical Care Medicine. 182(10). 1315–1320. 102 indexed citations
14.
Wolferen, S. A. van, Mariëlle C. van de Veerdonk, Gert-Jan Mauritz, et al.. (2010). Clinically Significant Change in Stroke Volume in Pulmonary Hypertension. CHEST Journal. 139(5). 1003–1009. 83 indexed citations
15.
Jacobs, Wouter, Anco Boonstra, J. Tim Marcus, Pieter E. Postmus, & Anton Vonk Noordegraaf. (2009). Addition of Prostanoids in Pulmonary Hypertension Deteriorating on Oral Therapy. The Journal of Heart and Lung Transplantation. 28(3). 280–284. 17 indexed citations
16.
Beek-Harmsen, Brechje J. van, et al.. (2008). Sarcoplasmic reticulum ATPase activity in type I and II skeletal muscle fibres of chronic heart failure patients. International Journal of Cardiology. 133(2). 185–190. 11 indexed citations
17.
Groepenhoff, Herman, Anton Vonk Noordegraaf, Anco Boonstra, et al.. (2008). Exercise Testing to Estimate Survival in Pulmonary Hypertension. Medicine & Science in Sports & Exercise. 40(10). 1725–1732. 111 indexed citations
18.
Gan, C. Tji, Jan‐Willem Lankhaar, Nico Westerhof, et al.. (2007). Noninvasively Assessed Pulmonary Artery Stiffness Predicts Mortality in Pulmonary Arterial Hypertension. CHEST Journal. 132(6). 1906–1912. 307 indexed citations
19.
Smit, Henk, Anton Vonk Noordegraaf, Anco Boonstra, Peter M. de Vries, & Pieter E. Postmus. (2005). Assessment of the Pulmonary Volume Pulse in Idiopathic Pulmonary Arterial Hypertension by Means of Electrical Impedance Tomography. Respiration. 73(5). 597–602. 19 indexed citations
20.
Beek-Harmsen, Brechje J. van, et al.. (2003). Maximum rate of oxygen consumption related to succinate dehydrogenase activity in skeletal muscle fibres of chronic heart failure patients and controls. Clinical Physiology and Functional Imaging. 23(6). 337–343. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Boonstra Breakdown of academic impact, for papers by Koen Marques Breakdown of academic impact, for papers by Robert A. Quaife Breakdown of academic impact, for papers by Jörg Winkler Breakdown of academic impact, for papers by Hani Shennib Breakdown of academic impact, for papers by Corey E. Ventetuolo Breakdown of academic impact, for papers by Dietmar Schranz Breakdown of academic impact, for papers by J. Tim Marcus Breakdown of academic impact, for papers by Daniel Staub Breakdown of academic impact, for papers by Igor E. Konstantinov
Rankless by CCL
2026